SCHEDULE: Carlyle Group Discloses 24.4% Stake in Medline Inc.
Beneficial Ownership Report
Carlyle Group Inc. and its affiliates have reported a beneficial ownership of 24.4% of Medline Inc.'s Class A Common Stock as of December 31, 2025.
Summary
- Carlyle Group Inc. and its various affiliated entities collectively beneficially own 215,303,036 shares of Medline Inc.'s Class A Common Stock.
- This ownership represents 24.4% of the total Class A Common Stock outstanding, based on 811,418,179 shares as of December 18, 2025.
- The reported ownership includes both directly held Class A Common Stock and shares underlying Common Units of Medline Holdings, LP, convertible on a one-to-one basis.
- Multiple Carlyle entities, including CG Subsidiary Holdings L.L.C., Carlyle Holdings I GP Inc., Carlyle Holdings II GP L.L.C., and various L.P. and L.L.C. funds, are listed as reporting persons, indicating a complex ownership structure.
- The filing is a Schedule 13G, indicating a passive investment stake by Carlyle Group Inc. and its affiliates.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral, as it is a routine disclosure of existing beneficial ownership and does not contain new operational or financial performance information.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that significant stakes by major private equity firms like Carlyle Group are common in the healthcare and medical supply sectors, often preceding or following major corporate transactions such as initial public offerings or leveraged buyouts. This filing confirms Carlyle's continued substantial influence over Medline Inc., a key player in medical supplies.
Stakeholder Impact
- Shareholders: Confirms a significant institutional shareholder, Carlyle Group, holds a substantial stake, which can influence corporate strategy and potential future transactions.
- Management: Carlyle Group's significant ownership implies a strong voice in strategic decisions and corporate governance.
Key Dates
| Date | Description |
|---|---|
| 2025-12-18 | Date of Class A Common Stock outstanding calculation (811,418,179 shares). |
| 2025-12-31 | Date of event which requires the filing of this statement. |
| 2026-02-13 | Date of filing of the Schedule 13G statement. |
Keywords
Medline Inc., Carlyle Group, Beneficial Ownership, Schedule 13G, Class A Common Stock, Institutional Ownership, Private Equity, Healthcare, Medical Supplies
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.